Other languages Exact Sciences Corporation

Equities

EXAS

US30063P1057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
63.48 ^USD	+0.41%		-12.98%	-14.19%

Apr. 17	Exact Sciences Corporation announced that it has received $266.75 million in funding	CI
Apr. 15	Sector Update: Health Care Stocks Advance Premarket Monday	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exact Sciences Corporation Announces Executive Changes	Apr. 15
Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes	Apr. 11
Exact Sciences Corp. Advances Development of Non-Endoscopic Oncoguard Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer	Mar. 28
Exact Sciences Insider Sold Shares Worth $287,500, According to a Recent SEC Filing	Mar. 05
Exact Sciences Insider Sold Shares Worth $356,302, According to a Recent SEC Filing	Feb. 29
Exact Sciences Insider Sold Shares Worth $305,963, According to a Recent SEC Filing	Feb. 23
Exact Sciences Corporation Provides Earnings Guidance for the first quarter and Year 2024	Feb. 21
Exact Sciences' Q4 Loss Narrows, Revenue Increases; Sets 2024 Revenue Forecast	Feb. 21
Exact Sciences Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21
Exact Sciences Sees 17% Growth in Q4 Revenue	Jan. 08
Exact Sciences Corporation Provides Revenue Guidance for the Year Ended December 31, 2023 and 2024	Jan. 07
Exact Sciences Corporation Announces Jeff Elliott Plans to Step Down as Executive Vice President	Jan. 07
Exact Sciences Corp. Presents Multiple Studies At San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients	Dec. 01
Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy Over Colorectal Cancer Screening Test	Nov. 17
Exact Sciences Q3 EPS, Revenue Increase; Lifts 2023 Revenue Outlook	Nov. 01
Exact Sciences Corporation Raises Revenue Guidance for the Full Year 2023	Nov. 01
Exact Sciences Corporation Appoints Timothy Scannell as Director and Member of Audit and Finance Committee	Nov. 01
Exact Sciences Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01
Exact Sciences Corp. Announces Late-Breaking Data from the Pivotal Blue-C Trial	23-10-22
Exact Sciences Insider Sold Shares Worth $864,835, According to a Recent SEC Filing	23-10-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Exact Sciences Corporation

Equities

EXAS

US30063P1057

Other languages

Filters